NCT05683093 Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood
| NCT ID | NCT05683093 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oxford |
| Condition | Young Adult |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-11-17 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-11-17 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to understand more about why young people who were born to a hypertensive pregnancy may have increased risk of high blood pressure and are often at increased risk of heart and blood vessel disease later in life.
Eligibility Criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study * Male or female, aged 30 to 40 years at time of enrolment * Participant previously took part in the ALSPAC study * Able (in the investigator's opinion) and willing to comply with all study requirements * Adequate understanding of verbal and written English Exclusion Criteria: * Pregnant or lactating when they are due to attend for study visit 1 * Less than six months postpartum * Planning to donate blood within two weeks prior to study visit 1 * Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study * Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status For exclusion of MRI component only: * Unsuitable for MRI based on participant screening; the participant may still be included in other parts of the study
Contact & Investigator
Adam J Lewandowski
PRINCIPAL INVESTIGATOR
Cardiovascular Clinical Research Facility
Frequently Asked Questions
Who can join the NCT05683093 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 40 Years, studying Young Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05683093 currently recruiting?
Yes, NCT05683093 is actively recruiting participants. Contact the research team at clarity@cardiov.ox.ac.uk for enrollment information.
Where is the NCT05683093 trial being conducted?
This trial is being conducted at Oxford, United Kingdom.
Who is sponsoring the NCT05683093 clinical trial?
NCT05683093 is sponsored by University of Oxford. The principal investigator is Adam J Lewandowski at Cardiovascular Clinical Research Facility. The trial plans to enroll 200 participants.